The coronavirus vaccine from AstraZeneca may not be very effective for people over the age of 65. German government sources reported this to tabloid Bild and Handelsblatt. According to the BIld, the Berlin government fears that the European authorities may not approve the drug produced by Astrazeneca for the over 65s. The British-Swedish company, which developed its vaccine in collaboration with the University of Oxford, warned the European Union on Friday that planned supplies may not be delivered until the end of March.
–
Related posts:
The average price of LFP batteries is at an all-time low, and Chinese electric vehicle batteries are...
Exposing the Abuses: Indonesian Healthcare Students in the Netherlands
Bank offers innovative consumer loans
Major Decisions Imminent From Egypt's Central Bank...and Pound Breaks 24.61 Levels By Investing.com